Prime Minister Shinzo Abe, Japan’s longest-serving premier, announced his resignation due to poor health on Friday, ending a stint at the helm of the world’s third-biggest economy in which he sought to revive growth and bolster its defences.
“I have decided that I will step down as prime minister, with the belief that I cannot continue being prime minister if I do not have the confidence that I can carry out the job entrusted to me by the people,” Abe, 65, told a news conference.
He said he had decided to step down now to avoid a political vacuum as the country copes with its novel coronavirus outbreak.
“I apologize from the bottom of my heart that, despite all of the support from the Japanese people, I am leaving the post with one full year left in my term and in the midst of various policies and coronavirus,” Abe said. He similarly quit in 2007 after one year as premier, citing illness.
Abe has battled the disease ulcerative colitis for years, and two recent hospital visits within a week had fanned questions on whether he could stay in the job until the end of his term as ruling party leader, and hence premier, in September 2021.
Abe did not want to cause trouble by resigning suddenly, but his condition had recurred and was at risk of worsening, the Jiji news agency quoted him as saying.
The resignation will trigger a leadership race in the LDP, the winner of which must be formally elected in parliament. The new party leader will hold the post for the rest of Abe’s term.
Whoever wins the party poll is likely to keep Abe’s reflationary “Abenomics” policies as Japan struggles with the impact of the coronavirus, but may have trouble emulating the political longevity that may be Abe’s biggest legacy.
“The broad picture remains intact. In terms of economic and fiscal policy, the focus remains very much on reflation,” said Jesper Koll, senior adviser to asset manager WisdomTree Investments.
“Longevity will be a struggle.”
On Monday, Abe surpassed a record for longest consecutive tenure as premier set by his great-uncle Eisaku Sato half a century ago.
Abe’s resignation also comes amid an uncertain geopolitical environment, including an intensifying confrontation between the United States and China and ahead of the U.S. presidential election in November.
The conservative Abe returned as prime minister for a rare second term in December 2012, pledging to revive growth with his “Abenomics” mix of hyper-easy monetary policy, fiscal spending and reforms. He also pledged to beef up Japan’s defences and aimed to revise the pacifist constitution.
Under fire for his handling of the coronavirus and scandals among party members, Abe has recently seen his support fall to one of the lowest levels of his nearly eight years in office.
Japan has not suffered the explosive surge in virus cases seen elsewhere, but Abe had drawn fire for a clumsy early response and what critics see as a lack of leadership as infections spread.
In the second quarter, Japan was hit by its biggest economic slump on record as the pandemic emptied shopping malls and crushed demand for cars and other exports, bolstering the case for bolder policy action to avert a deeper recession.
Abe kept his promises to strengthen defences, boosting spending on the military after years of declines and expanding its capacity to project power abroad.
In a historic shift in 2014, his government re-interpreted the constitution to allow Japanese troops to fight abroad for the first time since World War Two.
A year later, Japan adopted laws scrapping a ban on exercising the right of collective self-defence or defending a friendly country under attack.
But Abe proved unable to revise the U.S.-drafted, post-war constitution’s pacifist Article 9, a personal mission that also eluded his grandfather, Nobusuke Kishi, who quit as premier in 1960 because of uproar over a U.S-Japan security pact.
Abe resigned from his first stint as prime minister in 2007, citing ill-health after a year plagued by scandals in his cabinet and a huge election loss for his ruling party. He had since kept his illness in check with medicine that was not previously available.